Quality-of-life Impact of Newly Formed Digitalized Printed Paper Inserted Into Eyeglasses

NCT ID: NCT05857189

Last Updated: 2023-05-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

18 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-01-01

Study Completion Date

2023-05-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A straightforward, user-friendly removable orbital prosthesis is a practical choice for effective rehabilitation in such patients with defective eyes. One of the essential elements for a good recovery is the retention of the prosthesis. The prosthesis can be retained by using a spectacle frame, conformers, adhesives, osseointegrated implants, magnets, or buttons. Only osseointegrated prostheses in the maxillofacial region can use semi-precision attachments.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Aim: Using of eyeglasses with newly formed digitalized printed paper of mirrored photograph of an intact eye for orbital defected patients to restore the esthetic appearance. An evaluation of the quality of life for patients using temporalized eyeglasses with digitalized printed paper of mirrored photographs of a healthy eye.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Orbital Deformity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Crossover between experimental and traditional groups after 2 weeks of lapse time. both groups will be compared to healthy control
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental group

Group Type EXPERIMENTAL

Digitalized printed paper

Intervention Type DEVICE

Patients will receive a newly formed digitalized printed paper inserted into eyeglasses

Control group

Group Type ACTIVE_COMPARATOR

Traditional drawing image

Intervention Type DEVICE

Patients will receive eyeglasses that hold a traditional drawing image of the eye

Healthy control group

patients in this group will be observed as a normal reference group

Group Type OTHER

Healthy controls

Intervention Type OTHER

Patients will include volunteering participants with un defected eye

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Digitalized printed paper

Patients will receive a newly formed digitalized printed paper inserted into eyeglasses

Intervention Type DEVICE

Traditional drawing image

Patients will receive eyeglasses that hold a traditional drawing image of the eye

Intervention Type DEVICE

Healthy controls

Patients will include volunteering participants with un defected eye

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with an orbital defective eye (type I).
* Patients age more than 6 years.
* Patients with a unilateral enucleated eye.
* Skin-grafted orbital defects with a lack of natural retentive means either natural undercuts or retaining implants.
* Patients who are not prone to be received any prosthetic rehabilitation either for financial, age, or transportation problems of material that are needed for fabrication of prosthetic eye.

Exclusion Criteria

* Patients with the bilateral enucleated eye.
* Patients with primary signs of skin inflammation, infection, or untreated local disease
* Patients refusing to wear any eyeglasses.
* Patients with ocular defects.
Minimum Eligible Age

6 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hams Hamed Abdelrahman

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hams Hamed Abdelrahman

Assistant lecturer of DPH and Clinical statistician

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Alexandria Faculty of Dentistry

Alexandria, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ahmed k Farag, BDS

Role: CONTACT

01064557964

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ahmed K Farag, BDS

Role: primary

01064557964

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

QoL_2022

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.